ITMN A and B, novel inhibitors of the HCVNS3/4 protease retain their potency against VX-950 and BILN-2016 resistant NS3/4 protease mutants and an IFN-A-2A resistant HCV replicon

S Seiwert,SW Andrews,HL Yang, H Tan, B Marifino, R Radhakishnan,E Cheung,R Rieger, YT Jiang, A Kennedy, S Wenglowsky, M Madduru, J Bencsik, M Liang, B Woodward,K Condroski, C Lemieu,LP Opie,G Hingorani,WE Delaney,HL Yang, A Kaup, M Gale, J Winkler,J Josey,LM Blatt

HEPATOLOGY（2005）

Cited 0|Views3

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined